| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/23/2008 | CN100382782C Release-improved pharmaceutical formulation |
| 04/23/2008 | CA2607544A1 A pharmaceutical formulation and its use for the treatment of acquired immune deficiency syndrome (aids) and other aids related diseases and a process for its preparation |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361674 7, 8 and 9-substituted tetracycline compounds |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361657 Drugs for treatment of respiratory syncytial virus and salt formation |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361459 Antiviral inhibition of capsid proteins |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 04/22/2008 | US7361348 Immunogenic glycopeptides, screening, preparation and uses |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2321687C Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 04/22/2008 | CA2279932C 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives |
| 04/22/2008 | CA2265993C Novel antimicrobial cosmetic compositions |
| 04/22/2008 | CA2129542C Pharmaceutical preparation based on rhamnolipid |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008045945A1 Benzindole derivatives and method of treating hiv/aids |
| 04/17/2008 | WO2008045852A2 Purification of streptococcus pneumoniae type 3 polysaccharides |
| 04/17/2008 | WO2008045543A1 Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use |
| 04/17/2008 | WO2008045507A2 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 04/17/2008 | WO2008045135A2 Systems providing antimicrobial activity to an environment |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044734A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | WO2008044733A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044627A1 Prophylactic/therapeutic agent for liver disorder utilizing baculovirus |
| 04/17/2008 | WO2008044611A1 Ipv-dpt vaccine |
| 04/17/2008 | WO2008044562A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | WO2008044261A1 Use of amiodarone and amiodarone analogues as antiviral agents |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043840A2 Anti-infective thiourea compounds |
| 04/17/2008 | WO2008043829A2 Method for treating hiv-1 infection by the combined administration of nevirapine, tenofovir and emtricitabine |
| 04/17/2008 | WO2008043791A2 Thiophene derivatives for treating hepatitis c |
| 04/17/2008 | WO2008043774A1 Vaccine comprising an oil in water emulsion adjuvant |
| 04/17/2008 | WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 04/17/2008 | WO2008043704A1 Hcv nucleoside inhibitor |
| 04/17/2008 | WO2008043570A1 Interferon type i supporting compounds |
| 04/17/2008 | WO2008043424A2 Composition to treat or prevent gastrointestinal infection |
| 04/17/2008 | WO2008043180A1 Immunostimulatory composition comprising recombinant bcg mycobacterium expressing mammalian cysteine protease |
| 04/17/2008 | WO2008043175A1 SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 04/17/2008 | WO2008025848A3 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 04/17/2008 | WO2008021936A3 Hepatitis c virus inhibitors |
| 04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
| 04/17/2008 | WO2007138381A3 Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections |
| 04/17/2008 | WO2007125423A3 Molecules which bind to the dimerization initiation site (dis) of hiv rna, their synthesis and their applications as drugs |
| 04/17/2008 | WO2007124224A3 Method for delivering particulate drugs to tissues |
| 04/17/2008 | WO2007114978A3 Method for treating hiv infection through co-administration of tipranavir and pa-457 |
| 04/17/2008 | WO2007103988A3 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090912 Compositions containing prodrugs of florfenicol and methods of use |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090900 Antibiotic bushrin |
| 04/17/2008 | US20080090884 Antimicrobial [3.1.0] bicyclohexylphenyl- oxazolidinone derivatives and analogues |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090849 Protein kinase inhibitors, in particular inhibitory properties for CIV1 protein; N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride; fungal diseases such as candidiases, aspergilloses, histoplasmoses and coccidoidoses; fungicidal infections |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090841 pyrazinoylguanidine derivatives; more potent, more specific, and/or absorbed less rapidly from mucosal surfaces, and/or are less reversible, give a prolonged pharmacodynamic half-life; treating anthrax, chronic bronchitis, cystic fibrosis,chronic obstructive pulmonary disease, emphysema, pneumonia |
| 04/17/2008 | US20080090825 Metallo-beta-lactamase inhibitors |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090814 For treating infections by hepatitis C virus; 4-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-pyridazin-3-one 16 |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090789 Tigecycline crystalline forms and processes for preparation thereof |
| 04/17/2008 | US20080090788 Chemical Compounds |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090781 Formulations Containing Alkylphosphocholines Using Novel Negative Charge Carriers |
| 04/17/2008 | US20080090773 Antibacterial activity; 4''-O-{3-[3-(3-Carboxy-1,4-dihydro-1-dimethylamino-4-oxo-6-quinolinyl)propylamino]propionyl}-6-O-methylerythromycin A |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089963 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 04/17/2008 | US20080089953 Multi-dose; no conventional preservatives; also comprises borate/propylene glycol, borate/glycerol |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089941 Fucoidan compositions and methods |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089903 Cd4+t-lymphocyte-specific hepatitis c virus epitopes |
| 04/17/2008 | US20080089902 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/17/2008 | US20080089901 Hivcon: an hiv immunogen and uses thereof |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | DE202008002217U1 Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und/oder Pelargonium reniforme zur Behandlung von kutanen Virusinfektionen Use of extracts from roots of Pelargonium sidoides and / or Pelargonium reniforme for the treatment of cutaneous viral infections |
| 04/17/2008 | CA2666440A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | CA2666314A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 04/17/2008 | CA2666058A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | CA2665769A1 Composition to treat and/or prevent gastrointestinal infection |
| 04/17/2008 | CA2665169A1 Purification of streptococcus pneumoniae type 3 polysaccharides |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664915A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | CA2664799A1 Ipv-dpt vaccine |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |